Recent evidence shows that TGF-β can drive MAF expression to promote exhaustion of conventional αβ CD8+ T cells in melanoma, resulting in defective anti-tumor responses (Giordano et al., 2015). The gene discussed is CD8A; the disease is neoplasm.